Toxicity of neocarzinostatin (NSC-69856): an antitumor antibiotic with radiomimetic and antigenic characteristics.
D000707:Anaphylaxis / Q000139:chemically induced; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000097:blood / Q000276:immunology / Q000633:toxicity*; D000917:Antibody Formation; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D000941:Antigens / Q000008:administration & dosage / Q000633:toxicity*; D001426:Bacterial Proteins / Q000008:administration & dosage / Q000276:immunology / Q000633:toxicity*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D005779:Immunodiffusion; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D011233:Precipitin Tests; D013997:Time Factors; D014511:Uremia / Q000139:chemically induced
D000903:Antibiotics, Antineoplastic; D000936:Antigen-Antibody Complex; D000941:Antigens; D001426:Bacterial Proteins